This contract expires in 17 days (Sep 30, 2026).

Browse related active opportunities

FIRM FIXED PRICENO SET ASIDE USED.

ABBOTT LABORATORIES INC. - ANTI - HCV - IMMUNOASSAY TESTING

PIID: W81K0022P0154Solicitation ID: W81K0022Q0104
Signed Date: Dec 1, 2025Effective Date: Jul 1, 2022End Date: Closes in 17 days
Award $
$1.4M
Vendor
ABBOTT LABORATORIES INC.
NAICS
325413
Signed Date
Dec 1, 2025

Key Details

Dollars Obligated
$1.4M
Base & All Options
Awarding Agency
Department of Defense
Awarding Sub-Agency
Department of the Army
Product Service Code
6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Extent Competed
COMPETED UNDER SAP
Number of Offers
3
Place of Performance
NORTH CHICAGO, IL, 600641370, CD-IL-10

Description

ANTI - HCV - IMMUNOASSAY TESTING

Context & Analysis

On Dec 1, 2025, Department of Defense obligated $1,376,638.02 to ABBOTT LABORATORIES INC. for anti - hcv - immunoassay testing. The award is classified under NAICS 325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING and issued as a firm fixed price contract. Competition extent: competed under sap with 3 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in NORTH CHICAGO, IL. The contract is scheduled through Sep 30, 2026 — approximately 1 month remaining. This award is one of several similar procurements from Department of Defense under NAICS 325413 — related awards are listed below.

Contractor Information

UEI: NH3LDK8CFAK7
CAGE Code: 33110
Location: NORTH CHICAGO, IL

Stay Updated

Get notified about new opportunities matching your interests.

Related